期刊论文详细信息
Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
Article
关键词: ATHEROSCLEROTIC CORONARY-ARTERIES;    CHOLESTEROL-LOWERING THERAPY;    HORMONE REPLACEMENT THERAPY;    NITRIC-OXIDE;    ESTROGEN REPLACEMENT;    FOLLOW-UP;    CARDIOVASCULAR-DISEASE;    MYOCARDIAL-INFARCTION;    BRACHIAL-ARTERY;    MENSTRUAL-CYCLE;   
DOI  :  10.1161/01.CIR.98.12.1158
来源: SCIE
【 摘 要 】

Background-Epidemiological studies indicate that estrogen replacement therapy decreases the risk of cardiovascular events in postmenopausal women. Estrogen may confer cardiovascular protection by improving endothelial function because it increases endothelium-dependent vasodilation. It is not known whether progesterone attenuates the beneficial effects of estrogen on endothelial function. Methods and Results-Seventeen postmenopausal women with mild hypercholesterolemia were enrolled in a placebo-controlled, crossover trial to evaluate the effect of transdermal estradiol, with and without vaginal micronized progesterone, on endothelium-dependent vasodilation in a peripheral conduit artery. Brachial artery diameter was measured with high-resolution B-mode ultrasonography. To assess endothelium-dependent vasodilation, brachial artery diameter was determined at baseline and after a flow stimulus induced by reactive hyperemia. To assess endothelium-independent vasodilation, brachial artery diameter was measured after administration of sublingual nitroglycerin. During estradiol therapy, reactive hyperemia caused an 11.1+/-1.0% change in brachial artery diameter compared with 4.7+/-0.6% during placebo therapy (P<0.001). Progesterone did not significantly attenuate this improvement. During combined estrogen and progesterone therapy, flow-mediated vasodilation of the brachial artery was 9.6+/-0.8% (P=NS versus estradiol alone). Endothelium-independent vasodilation was not altered by estradiol therapy, either with or without progesterone, compared with placebo. There was a modest decrease in total and LDL cholesterol during treatment both with estradiol alone and when estradiol was combined with progesterone (all P<0.001 versus placebo). In a multivariate analysis that included serum estradiol, progesterone, total and LDL cholesterol concentrations, blood pressure, and heart rate, only the estradiol level was a significant predictor of endothelium-dependent vasodilation. Conclusions-The addition of micronized progesterone does not attenuate the favorable effect of estradiol on endothelium-dependent vasodilation. The vasoprotective effect of hormone replacement therapy may extend beyond its beneficial actions on lipids.

【 授权许可】

Free   

  文献评价指标  
  下载次数:0次 浏览次数:3次